A test that’s capable of identifying hundreds of organisms has received FDA approval to detect 1 more—Candida auris, a potentially fatal emerging pathogen that often is multidrug resistant.
The test uses a technology known as matrix-assisted laser desorption/ionization mass spectrometry along with a reference organism database to identify 424 clinically relevant bacteria and yeast species. It’s the first test approved to recognize C auris, which can cause bloodstream infections, especially in patients who are hospitalized or in a nursing home. More than 1 in 3 patients with invasive C auris infection die, according the US Centers for Disease Control and Prevention (CDC).
Voelker R. New Test Identifies Candida auris. JAMA. 2018;319(21):2164. doi:10.1001/jama.2018.6922
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: